⌕
Nanobiotix · NBTX · Nasdaq
Tenet — · insufficient data
Compare
$28.54−6.90%At close
$28.54−2.12 (−6.90%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Data under review. Our nightly checks found a problem in this company's reported figures on Oct 23, 2026, so we are not showing its score, ratios or statements for now. The figures come back after they pass the checks two nights in a row. The price and chart are live.

Nanobiotix (NBTX) News

What's actually happening: chronological and provenance-stamped. News is context, not a signal.

Sources News publishers NewsHow we compute thisNot investment advice

● GlobeNewsWireOct 24, 2026 · 07:00 ETCOMPANY'S OWN WORDS
NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma

In 24 heavily pre-treated patients with advanced primary cutaneous melanoma whose cancer had progressed after multiple prior lines of therapy including anti-PD-1 therapy, data continue to show an acceptable safety profil…

● Defense WorldOct 3, 2026 · 05:01 ET
Nanobiotix (NASDAQ:NBTX) Shares Gap Down – Time to Sell?

Nanobiotix S.A. - Sponsored ADR (NASDAQ: NBTX - Get Free Report)'s stock price gapped down before the market opened on Thursday. The stock had previously closed at $31.16, but opened at $29.99. Nanobiotix shares last tra…

● Defense WorldOct 2, 2026 · 06:21 ET
Nanobiotix (NASDAQ:NBTX) Sees Large Volume Increase – Still a Buy?

Nanobiotix S.A. - Sponsored ADR (NASDAQ: NBTX - Get Free Report) saw an uptick in trading volume on Wednesday. 90,160 shares changed hands during trading, an increase of 1% from the previous session's volume of 88,938 sh…

● GlobeNewsWireOct 1, 2026 · 16:15 ETCOMPANY'S OWN WORDS
NANOBIOTIX Announces the Appointment of Arnd Christ as Chief Financial Officer

PARIS and CAMBRIDGE, Mass., Oct. 01, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatmen…

● GlobeNewsWireSep 24, 2026 · 16:15 ETCOMPANY'S OWN WORDS
NANOBIOTIX Provides First Half 2026 Operational and Financial Update

PARIS and CAMBRIDGE, Mass., Sept. 24, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treat…

● Defense WorldSep 21, 2026 · 04:29 ET
Nanobiotix S.A. – Sponsored ADR (NASDAQ:NBTX) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Nanobiotix S.A. - Sponsored ADR (NASDAQ: NBTX - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the six brokerages that are presently covering the company, Marketbeat repor…

● GlobeNewsWireSep 14, 2026 · 02:00 ETCOMPANY'S OWN WORDS
NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer

All 24 patients completed treatment with no dose-limiting toxicities, no Grade 3 or higher adverse events related to JNJ-1900 (NBTXR3 or to the injection procedure, and intratumoral injection was deemed feasible One-year…

● GlobeNewsWireSep 9, 2026 · 16:15 ETCOMPANY'S OWN WORDS
NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

PARIS and CAMBRIDGE, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatme…

No upcoming events in the feeds.

Article counts from the last market-wide feed page, across every symbol we track and not just NBTX · day move from the quote feed. Equal counts are listed alphabetically, not ranked. Coverage ≠ importance.

The feed is purely chronological. No materiality ranking, no hidden sentiment score. Timestamps are publisher-reported and arrive with no timezone, so they are read and shown on the US market clock (ET); thumbnails come from each article's image field; day moves from the quote feed. Copies of the same story are collapsed on link or normalized headline, and a company's press release is kept over any syndicated copy of it; "company's own words" means the release title leads with the company's name and the wire names no other organisation first as its issuer; "earnings-tied" is a keyword match while a report date is upcoming. Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.